Bassetti, M; Scudeller, L; Giacobbe, D R; Lamoth, F; Righi, E; Zuccaro, V; Grecchi, C; Rebuffi, C; Akova, M; Alastruey-Izquierdo, A; Arıkan Akdagli, S; Azoulay, E; Blot, S; Cornely, O; Lass-Flörl, C; Koehler, P; Cuenca-Estrella, M; de Lange, D W; De Rosa, F G; De Waele, J J; Dimopoulos, G; Garnacho-Montero, J; Hoenigl, M; Kanj, S S; Maertens, J; Martin-Loeches, I; Muñoz, P; Kullberg, B J; Agvald-Ohman, C; Poulakou, G; Rello, J; Sanguinetti, M; Taccone, F S; Timsit, J-F; Torres, A; Vazquez, J A; Calandra, T; From the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the European Society of Intensive Care Medicine (ESICM), the European Confederation of Medical Mycology (ECMM), and the Mycoses Study Group Education and Research Consortium (MSGERC)
(Wiley-Blackwell, 2019-04)
Background: The reliability of diagnostic criteria for invasive fungal diseases (IFD) developed for severely immunocompromised patients is questionable in critically ill adult patients in intensive care units (ICU). ...